Tony Weisman - Feb 29, 2024 Form 4 Insider Report for Klaviyo, Inc. (KVYO)

Role
Director
Signature
/s/ Landon Edmond, Attorney-in-Fact
Stock symbol
KVYO
Transactions as of
Feb 29, 2024
Transactions value $
-$865,658
Form type
4
Date filed
3/4/2024, 06:13 PM
Previous filing
Sep 20, 2023
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KVYO Series A Common Stock Conversion of derivative security +33.3K 33.3K Feb 29, 2024 Direct F1
transaction KVYO Series A Common Stock Sale -$866K -33.3K -100% $25.97 0 Feb 29, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVYO Series B Common Stock Conversion of derivative security $0 -33.3K -30.77% $0.00 75K Feb 29, 2024 Series A Common Stock 33.3K Direct F1, F3
holding KVYO Series B Common Stock 20.8K Feb 29, 2024 Series A Common Stock 20.8K By trust F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.91 to $26.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Consists of (a) 66,667 shares of Series B Common Stock and (b) 8,333 unvested restricted stock units. On March 1, 2024, the remaining 8,333 RSUs vested and settled as 8,333 shares of Series B Common Stock according to the previously reported vesting schedule applicable to such grant.
F4 Shares held by Tony G. Weisman TTEE Tony G. Weisman Declaration of Trust Dated 06-27-2000, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.